Narcolepsy Type 2 — ALKS 2680

What taking part involves

A screening visit at our Miami office confirms whether a study is a fit. It is provided at no cost and you are under no obligation to continue.

Who may be able to take part

• Adults 18–70
• Confirmed NT2 diagnosis (MSLT/PSG)
• BMI 18–40 kg/m²
• Washout of current narcolepsy treatment

Final eligibility is determined at your free screening visit.

About this condition

Narcolepsy Type 2

Narcolepsy type 2 brings the same persistent, overwhelming daytime sleepiness as type 1, but without cataplexy. People fall asleep unintentionally during quiet activities, and short naps may feel refreshing at first. Broken nighttime sleep, sleep paralysis and vivid dreams at sleep onset can also occur.

Hypocretin levels are usually normal in type 2, and the underlying cause is not yet well understood. Diagnosis follows the same path as type 1: an overnight sleep study to rule out other explanations, followed the next day by a multiple sleep latency test that measures how quickly someone falls asleep and how quickly they enter REM sleep during scheduled naps.

Other studies for this condition

If this one is not a fit, another may be. Our coordinators check you against every open protocol, not just the one you applied for.

Registry record

This study is listed in the public registry of clinical studies. The record below is maintained by the study sponsor.

What happens after you apply

1. 1
   Apply Online

   Fill out the short form below — it takes about two minutes and is completely confidential.

2. 2
   Pre-Screening Call

   A bilingual research coordinator calls you within 24 hours to ask brief eligibility questions.

3. 3
   Free Screening Visit

   Visit our Miami office for a no-cost medical evaluation: history, physical exam, and any required tests.

4. 4
   Enroll & Begin

   If eligible, you are officially enrolled and begin the study under direct physician supervision.